Ardent Health CEO granted 103,653 RSUs

Caspers Dave reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Caspers Dave reported acquisition or exercise transactions in this Form 4 filing.

Ardent Health, Inc. reported that CEO and President Dave Caspers received an equity grant of 103,653 shares of Common Stock in the form of restricted stock units. These units vest in three substantially equal installments on each anniversary of July 1, 2026, as long as he remains with the company through each vesting date.

Following this award, Caspers directly holds 174,930 shares of Ardent Health common stock. The grant is compensation-related and was not an open-market purchase, as it carried a grant price of $0.00 per share.

Insider Trade Summary

Grant/Award: 103,653 shares

Grant/Award 1 txn

Insider Caspers Dave

Role CEO and President

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	103,653	$0.00	$0.00

Holdings After Transaction: Common Stock — 174,930 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units that vest in three substantially equal installments on each anniversary of July 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date.

Key Figures

RSU grant size: 103,653 shares Grant price per share: $0.00 per share Shares held after grant: 174,930 shares +2 more

5 metrics

RSU grant size 103,653 shares Restricted stock units granted to CEO Dave Caspers

Grant price per share $0.00 per share Equity award classified as compensation grant

Shares held after grant 174,930 shares Dave Caspers’ direct holdings following the transaction

Vesting schedule 3 equal installments Annual vesting on each anniversary of July 1, 2026

Transaction code A Grant, award, or other acquisition of securities

Key Terms

restricted stock units, vesting, transaction code "A", Common Stock, +1 more

5 terms

restricted stock units financial

"Represents restricted stock units that vest in three substantially equal installments"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting financial

"units that vest in three substantially equal installments on each anniversary"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

transaction code "A" regulatory

"transaction_code_description": "Grant, award, or other acquisition""

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ardent Health (ARDT) report for CEO Dave Caspers?

Ardent Health reported that CEO Dave Caspers received 103,653 restricted stock units as an equity grant. These compensation-related units convert into common stock over time if he continues serving the company through future vesting dates.

How many Ardent Health (ARDT) shares does CEO Dave Caspers hold after this Form 4?

After the reported grant, CEO Dave Caspers directly holds 174,930 shares of Ardent Health common stock. This figure reflects his ownership following the award of 103,653 restricted stock units disclosed in the Form 4 filing.

What is the vesting schedule for Dave Caspers’ 103,653 Ardent Health (ARDT) RSUs?

The 103,653 restricted stock units vest in three substantially equal installments on each anniversary of July 1, 2026. Vesting requires Dave Caspers to remain in continuous service with Ardent Health through each applicable vesting date.

Did Dave Caspers buy Ardent Health (ARDT) shares on the open market in this filing?

No, the Form 4 shows a compensation grant, not a market purchase. Dave Caspers was awarded 103,653 restricted stock units at a stated price of $0.00 per share, classified as a grant or award acquisition.

What does transaction code "A" mean in the Ardent Health (ARDT) Form 4?

Transaction code "A" indicates a grant, award, or other acquisition of securities. In this case, it reflects Dave Caspers receiving 103,653 restricted stock units as part of his equity compensation, rather than buying or selling shares on the market.

Are Dave Caspers’ new Ardent Health (ARDT) restricted stock units fully owned today?

The restricted stock units are granted now but vest over time. They vest in three substantially equal installments starting on July 1, 2026, and require his continued service with Ardent Health through each vesting date to fully receive the underlying shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 01:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Caspers Dave

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO and President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2026		A		103,653(1)	A	$0	174,930	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units that vest in three substantially equal installments on each anniversary of July 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date.

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)